RLAY
Relay Therapeutics, Inc.
A clinical-stage biotechnology company in Cambridge, Massachusetts, that designs small-molecule medicines by studying how proteins move and change shape, using its Dynamo platform to create "movies" of protein motion rather than static snapshots. Founded in 2015 as Allostery, Inc., it was renamed Relay Therapeutics to reflect that focus on protein motion, and its lead drug candidate targets a common mutation in breast cancer.
CUSIP: 75943R102HealthcareUS1 holder
Total Value
$10.12M
Total Shares
541.1K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
